Search - tctmd.com

Displaying 921 - 940 of 1082

Sort: Relevancy | Date

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

News Industry News

Clinical Trial Finds That Corevalve Reduces Rate of Death and Stroke in Sickest Patients with Aortic Stenosis

October 29, 2013

News Industry News

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

October 28, 2013

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

News Daily News

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

October 25, 2013

News Daily News

Innovative Stent-Grafts Safe, Feasible for High-Risk Complex Aortic Aneurysms

Yael L. Maxwell

October 25, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

News Industry News

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

October 17, 2013

News Daily News

‘Obesity Paradox’ Observed in TAVR Patients

Caitlin E. Cox

October 15, 2013

News Daily News

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

October 11, 2013

News Daily News

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

October 11, 2013

News Daily News

Transfemoral Access Not Only Option for TAVR

Yael L. Maxwell

October 04, 2013

News Daily News

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Yael L. Maxwell

September 27, 2013

News Industry News

Boston Scientific Reports Favorable Six-Month Results from Lotus™ Valve System Clinical Trial

September 17, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Daily News

Staged Stenting Best for Patients with Carotid Disease Prior to Heart Surgery

Caitlin E. Cox

August 05, 2013

News Daily News

Graft Infection After TEVAR or EVAR a Rare But Serious Complication

Jason Kahn

July 26, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

Una Comparativa de Tratamientos contra EAC Multivaso halla una Preservación LVEF Similar a los 10 Años

L.A. McKeown

July 24, 2013

Advertisement

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

Clinical Trial Finds That Corevalve Reduces Rate of Death and Stroke in Sickest Patients with Aortic Stenosis

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

Innovative Stent-Grafts Safe, Feasible for High-Risk Complex Aortic Aneurysms

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

‘Obesity Paradox’ Observed in TAVR Patients

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

Transfemoral Access Not Only Option for TAVR

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Boston Scientific Reports Favorable Six-Month Results from Lotus™ Valve System Clinical Trial

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Staged Stenting Best for Patients with Carotid Disease Prior to Heart Surgery

Graft Infection After TEVAR or EVAR a Rare But Serious Complication

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

Una Comparativa de Tratamientos contra EAC Multivaso halla una Preservación LVEF Similar a los 10 Años

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content